{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:20:13Z","timestamp":1791249613561,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,6,8]],"date-time":"2011-06-08T00:00:00Z","timestamp":1307491200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s12253-011-9398-3","type":"journal-article","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T00:40:50Z","timestamp":1307407250000},"page":"879-886","source":"Crossref","is-referenced-by-count":34,"title":["Smoking and Polymorphisms in Xenobiotic Metabolism and DNA Repair Genes are Additive Risk Factors Affecting Bladder Cancer in Northern Tunisia"],"prefix":"10.1007","volume":"17","author":[{"given":"Kamel","family":"Rouissi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slah","family":"Ouerhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bechr","family":"Hamrita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Bougatef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raja","family":"Marrakchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Cherif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Riadh","family":"Ben Slama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Bouzouita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Chebil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Ben Ammar Elgaaied","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,6,8]]},"reference":[{"key":"9398_CR1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0094-0143(21)00410-9","volume":"19","author":"SM Cohen","year":"1992","unstructured":"Cohen SM, Johansson SL (1992) Epidemiology and etiology of bladder cancer. Urol Clin North Am 19:421\u2013428","journal-title":"Urol Clin North Am"},{"key":"9398_CR2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0378-1119(94)00448-2","volume":"159","author":"H Raunio","year":"1995","unstructured":"Raunio H, Husgafvel-Pursiainen K, Anttila S et al (1995) Diagnosis of polymorphisms in carcinogen-activating and inactivating enzymes and cancer susceptibility: a review. Gene 159:113\u2013121","journal-title":"Gene"},{"key":"9398_CR3","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/bmj.320.7244.1257","volume":"320","author":"J Kaprio","year":"2000","unstructured":"Kaprio J (2000) Science, medicine, and the future. Genetic epidemiology. B Med J 320:1257\u20131259","journal-title":"B Med J"},{"key":"9398_CR4","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1093\/carcin\/21.11.1971","volume":"21","author":"JG Ford","year":"2000","unstructured":"Ford JG, Li Y, O\u2019Sullivan MM et al (2000) Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Carcinogenesis 21:1971\u20131975","journal-title":"Carcinogenesis"},{"key":"9398_CR5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.canlet.2004.10.006","volume":"219","author":"MR Karagas","year":"2005","unstructured":"Karagas MR, Park S, Warren A et al (2005) Gender, smoking, glutathione- S-transferase variants and bladder cancer incidence: a population-based study. Cancer Lett 219:63\u201369","journal-title":"Cancer Lett"},{"key":"9398_CR6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1525-1500.1998.00934.x","volume":"22","author":"SZ Abdel-Rahman","year":"1998","unstructured":"Abdel-Rahman SZ, Anwar WA, Abdel-Ala WE et al (1998) GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 22:129\u2013138","journal-title":"Cancer Detect Prev"},{"key":"9398_CR7","first-page":"312","volume":"45","author":"J Salagovic","year":"1998","unstructured":"Salagovic J, Kalina I, Stubna J et al (1998) Genetic polymorphism of glutathione S-transferase M1 and T1 as a risk factor in lung and bladder cancers. Neoplasma 45:312\u2013317","journal-title":"Neoplasma"},{"key":"9398_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0304-3835(98)00123-2","volume":"130","author":"JG Hengstler","year":"1998","unstructured":"Hengstler JG, Kett A, Arand M et al (1998) Glutathione S-transferase T1 and M1 gene defects in ovarian carcinoma. Cancer Lett 130:43\u201348","journal-title":"Cancer Lett"},{"key":"9398_CR9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3835(98)00183-9","volume":"132","author":"T Katoh","year":"1998","unstructured":"Katoh T, Inatomi H, Kim H et al (1998) Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk. Cancer Lett 132:147\u2013152","journal-title":"Cancer Lett"},{"key":"9398_CR10","first-page":"5230","volume":"55","author":"AF Badawi","year":"1995","unstructured":"Badawi AF, Hirvonen A, Bell DA et al (1995) Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adducts formation in human urinary bladder. Cancer Res 55:5230\u20135237","journal-title":"Cancer Res"},{"key":"9398_CR11","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1093\/carcin\/15.12.2781","volume":"15","author":"MT Kloth","year":"1994","unstructured":"Kloth MT, Gee RL, Messing EM et al (1994) Expression of N acetyltransferase (NAT) in cultured human uroepithelial cells. Carcinogenesis 15:2781\u20132787","journal-title":"Carcinogenesis"},{"key":"9398_CR12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/dna.1990.9.193","volume":"9","author":"M Blum","year":"1990","unstructured":"Blum M, Grant DM, McBride W et al (1990) Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9:193\u2013203","journal-title":"DNA Cell Biol"},{"key":"9398_CR13","first-page":"3915","volume":"56","author":"J Brockmoller","year":"1996","unstructured":"Brockmoller J, Cascorbi I, Kerb R et al (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56:3915\u20133925","journal-title":"Cancer Res"},{"key":"9398_CR14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/hmg\/4.2.231","volume":"4","author":"A Risch","year":"1995","unstructured":"Risch A, Wallace DMA, Bathers S et al (1995) Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 4:231\u2013236","journal-title":"Hum Mol Genet"},{"key":"9398_CR15","first-page":"619","volume":"9","author":"NM Probst-Hensch","year":"2000","unstructured":"Probst-Hensch NM, Bell DA, Watson MA et al (2000) N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenylhemoglobin adduct levels. Cancer Epidemiol Biomarkers Prev 9:619\u2013623","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9398_CR16","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/jnci\/86.9.712","volume":"86","author":"MC Yu","year":"1994","unstructured":"Yu MC, Skipper PL, Taghizadeh K et al (1994) Acetylator phenotype, aminobiphenylhemoglobin adduct levels, and bladder cancer risk in white, black, and Asian men in Los Angeles, California. J Nat Cancer Inst 86:712\u2013716","journal-title":"J Nat Cancer Inst"},{"key":"9398_CR17","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/carcin\/23.5.861","volume":"23","author":"L Airoldi","year":"2002","unstructured":"Airoldi L, Orsi F, Magagnotti C et al (2002) Determinants of 4-aminobiphenyl-DNA adducts in bladder cancer biopsies. Carcinogenesis 23:861\u2013866","journal-title":"Carcinogenesis"},{"key":"9398_CR18","first-page":"283","volume":"26","author":"GY Hao","year":"2004","unstructured":"Hao GY, Zhang WD, Chen YH et al (2004) Relationship between genetic polymorphism of NAT2 and susceptibility to urinary bladder cancer. Zhonghua Zhong Liu Za Zhi 26:283\u2013286","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"9398_CR19","first-page":"174","volume":"125","author":"XF Wu","year":"2006","unstructured":"Wu XF, Dzenis YA (2006) Guided self-assembly diblock copolymer thin films on chemically patterned substrartes. J Chem Phys 125:174\u20131777","journal-title":"J Chem Phys"},{"key":"9398_CR20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1464-410X.2007.06873.x","volume":"100","author":"CH Chen","year":"2007","unstructured":"Chen CH, Shun CT, Huang KH et al (2007) Stopping smoking might reduce tumour recurrence in non-muscle invasive bladder cancer. BJU Int 100:281\u2013286","journal-title":"BJU Int"},{"key":"9398_CR21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/1055-9965.EPI-05-0749","volume":"15","author":"M Garc\u0131a-Closas","year":"2006","unstructured":"Garc\u0131a-Closas M, Malats N, Real FX et al (2006) Genetic variation in the nucleotide-excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 15:536\u2013542","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9398_CR22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/02841860600812693","volume":"46","author":"S Sanyal","year":"2007","unstructured":"Sanyal S, De Verdier PJ, Steineck G et al (2007) Polymorphisms in XPD, XPC and the risk of death in patients with urinary bladder neoplasms. Acta Oncol 46:31\u201341","journal-title":"Acta Oncol"},{"key":"9398_CR23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.dnarep.2007.08.006","volume":"7","author":"Y Zhu","year":"2008","unstructured":"Zhu Y, Yang H, Chen Q et al (2008) Modulation of DNA damage\/DNA repair capacity by XPC polymorphisms. DNA Repair 7:141\u2013148","journal-title":"DNA Repair"},{"key":"9398_CR24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevOncog.v13.i2.20","volume":"13","author":"H Dworaczek","year":"2007","unstructured":"Dworaczek H, Xiao W (2007) Xeroderma pigmentosum: a glimpse into nucleotide-excision repair, genetic instability, and cancer. Crit Rev Oncog 13:159\u2013177","journal-title":"Crit Rev Oncog"},{"key":"9398_CR25","first-page":"1234","volume":"12","author":"M Shen","year":"2003","unstructured":"Shen M, Hung RJ, Brennan P et al (2003) Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy. Cancer Epidemiol Biomarkers Prev 12:1234\u20131240","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9398_CR26","first-page":"32","volume":"2","author":"A Sellami","year":"2000","unstructured":"Sellami A, Jlidi R, Hsa\u0131ri M et al (2000) Registre du cancer du Sud Tunisie 1997. H\u00f4pital Habib Bourguiba 2:32\u201335","journal-title":"H\u00f4pital Habib Bourguiba"},{"key":"9398_CR27","volume-title":"Molecular cloning: a laboratory manual","author":"J Sambrook","year":"1989","unstructured":"Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory, Cold Spring Harbor","edition":"2"},{"key":"9398_CR28","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1006\/abio.1996.0153","volume":"236","author":"M Arand","year":"1996","unstructured":"Arand M, Muhlbaur R, Hengstler J et al (1996) A multiplex polymerase chain reaction protocol for the simultaneous analysis of the glutathione S transferase GSTM1 and GSTT1 polymorphisms. Annal Biochem 236:384\u2013386","journal-title":"Annal Biochem"},{"key":"9398_CR29","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.bjc.6690727","volume":"81","author":"FI Hsieh","year":"1999","unstructured":"Hsieh FI, Pu YS, Chern HD et al (1999) Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br J Cancer 81:537\u2013541","journal-title":"Br J Cancer"},{"key":"9398_CR30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2131\/jts.33.187","volume":"33","author":"K Fukino","year":"2008","unstructured":"Fukino K, Sasaki Y, Hirai S et al (2008) Effect of N-acetyltransferase 2(NAT2), CYP2E1 and Glutathione-S-transferase (GST) genotypes on the serum Concentrations of isoniazid and metabolites in tuberculosis patients. J Toxicol Sci 33:187\u2013195","journal-title":"J Toxicol Sci"},{"key":"9398_CR31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-199502000-00001","volume":"5","author":"KP Vastis","year":"1995","unstructured":"Vastis KP, Weber WW, Bell DA et al (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics 5:1\u201317","journal-title":"Pharmacogenetics"},{"key":"9398_CR32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/carcin\/bgh058","volume":"25","author":"S Sanyal","year":"2004","unstructured":"Sanyal S, Festa F, Sakano S et al (2004) Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 25:729\u2013734","journal-title":"Carcinogenesis"},{"key":"9398_CR33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.mrgentox.2007.03.010","volume":"631","author":"K Ruyck De","year":"2007","unstructured":"De Ruyck K, Szaumkessel M, De Rudder I et al (2007) Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res 631:101\u2013110","journal-title":"Mutat Res"},{"key":"9398_CR34","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1080\/03610928308831078","volume":"22","author":"TW O\u2019Gorman","year":"1993","unstructured":"O\u2019Gorman TW, Woolson RF (1993) The effect of category choice on the odds ratio and several measures of association in case-control studies. Commun Stat 22:1157\u20131171","journal-title":"Commun Stat"},{"key":"9398_CR35","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/03014460600907517","volume":"33","author":"S Ouerhani","year":"2006","unstructured":"Ouerhani S, Tebourski F, Slama MR et al (2006) The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population. Ann Hum Biol 33:529\u2013535","journal-title":"Ann Hum Biol"},{"key":"9398_CR36","first-page":"1239","volume":"10","author":"S Garte","year":"2001","unstructured":"Garte S, Gaspari L, Alexandrie AK et al (2001) Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev 10:1239\u20131248","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9398_CR37","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s002040050366","volume":"71","author":"M Kempkes","year":"1996","unstructured":"Kempkes M, Golka K, Reich S et al (1996) Glutathione transferase GSTM1 and GSTT1 null genotypes as potential risk factors for urothelial cancer of the bladder. Arch Toxicol 71:123\u2013126","journal-title":"Arch Toxicol"},{"key":"9398_CR38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3835(01)00820-5","volume":"77","author":"SJ Lee","year":"2002","unstructured":"Lee SJ, Cho SH, Park SK et al (2002) Combined effect of glutathione S-transferase M1 and T1 genotypes on bladder cancer risk. Cancer Lett 77:173\u2013179","journal-title":"Cancer Lett"},{"key":"9398_CR39","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0090-4295(02)01892-7","volume":"60","author":"WJ Kim","year":"2002","unstructured":"Kim WJ, Kim H, Kim CH et al (2002) GSTT1-null genotype is a protective factor against bladder cancer. Urology 60:913\u2013918","journal-title":"Urology"},{"key":"9398_CR40","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1038\/sj.onc.1209374","volume":"25","author":"DW Hein","year":"2006","unstructured":"Hein DW (2006) N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Oncogene 25:1649\u20131658","journal-title":"Oncogene"},{"key":"9398_CR41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2407-8-109","volume":"28","author":"A Khedhaier","year":"2008","unstructured":"Khedhaier A, Hassen E, Bouaouina N et al (2008) Implication of xenobiotic metabolizing enzyme gene (CYP2E1, CYP2C19, CYP2D6, mEH and NAT2) polymorphisms in breast carcinoma. BMC Cancer 28:109\u2013121","journal-title":"BMC Cancer"},{"key":"9398_CR42","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1093\/carcin\/14.8.1689","volume":"14","author":"DA Bell","year":"1993","unstructured":"Bell DA, Taylor JA, Butler MA et al (1993) Genotype\/phenotype discordance for human arylamine N-acetyltransferase (NAT2) reveals a new slow-acetylator allele common in African-Americans. Carcinogenesis 14:1689\u20131692","journal-title":"Carcinogenesis"},{"key":"9398_CR43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.ftd.0000164197.95494.aa","volume":"27","author":"ES El Desoky","year":"2005","unstructured":"El Desoky ES, Abdel Salam YM, Salama RH et al (2005) NAT2*5\/*5 genotype (341T>C) is a potential risk factor for schistosomiasis- associated bladder cancer in Egyptians. Ther Drug Monit 27:297\u2013304","journal-title":"Ther Drug Monit"},{"key":"9398_CR44","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00008571-200108000-00006","volume":"11","author":"AJ Fretland","year":"2001","unstructured":"Fretland AJ, Doll MA, Leff MA et al (2001) Functional characterization of nucleotide polymorphisms in the coding region of N-acetyltransferase 1. Pharmacogenetics 11:511\u2013520","journal-title":"Pharmacogenetics"},{"key":"9398_CR45","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1097\/00008571-200411000-00002","volume":"14","author":"Y Zang","year":"2004","unstructured":"Zang Y, Zhao S, Doll MA et al (2004) The T341C (Ile114Thr) polymorphism of N-acetyltransferase 2 yields slow acetylator phenotype by enhanced protein degradation. Pharmacogenetics 14:717\u2013723","journal-title":"Pharmacogenetics"},{"key":"9398_CR46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(05)67137-1","volume":"366","author":"M Garcia-Closas","year":"2005","unstructured":"Garcia-Closas M, Malats N, Silverman D et al (2005) NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366:649\u2013659","journal-title":"Lancet"},{"key":"9398_CR47","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1158\/1055-9965.EPI-06-1041","volume":"16","author":"J Lin","year":"2007","unstructured":"Lin J, Swan GE, Shields PG et al (2007) Mutagen sensitivity and genetic variants in nucleotide-excision repair pathway: genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev 16:2065\u20132071","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9398_CR48","first-page":"1853","volume":"28","author":"L Fontana","year":"2008","unstructured":"Fontana L, Bosviel R, Delort L (2008) DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res 28:1853\u20131856","journal-title":"Anticancer Res"},{"key":"9398_CR49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cancergencyto.2009.06.007","volume":"195","author":"K Rouissi","year":"2009","unstructured":"Rouissi K, Ouerhani S, Oliveira E et al (2009) Polymorphisms in one-carbon metabolism pathway genes and risk for bladder cancer in a Tunisian population. Cancer Genet Cytogenet 195:43\u201353","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-011-9398-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12253-011-9398-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12253-011-9398-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T18:10:23Z","timestamp":1637777423000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12253-011-9398-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,8]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["9398"],"URL":"https:\/\/doi.org\/10.1007\/s12253-011-9398-3","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,8]]}}}